Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1-Reference-Cited by-同舟云学术

Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1

Published:1996-08 Issue:2 Volume:120 Page:168-173
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Chen Herbert,Carson-Walter Eleanor B.,Baylin Stephen B.,Nelkin Barry D.,Ball Douglas W.

Publisher

Elsevier BV

Subject

Surgery

Reference17 articles.

1. Ball DW, de Bustros A, Baylin SB. Medullary carcinoma of the thyroid. In: Braverman LE, Utiger RD, eds. The thyroid. 7th ed. Philadelphia: Lippincott, in press.

2. Germ-line mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A;Mulligan;Nature,1993

3. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC;Donis-Keller;Hum Mol Genet,1993

4. The molecular biology of medullary thyroid carcinoma: a model for cancer development and progression;Nelkin;JAMA,1989

5. Histopathological characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma;Bergholm;Cancer,1989

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers;2023-06-15

2. RREB1 promotes the development of parafollicular carcinogenesis through the Ras-Raf-1-ELK3 signaling pathway;Nucleosides, Nucleotides & Nucleic Acids;2022-06-23

3. ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation;Oncogene;2013-09-16

4. Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch;Neuroendocrinology;2013

5. Identification of a Novel Raf-1 Pathway Activator that Inhibits Gastrointestinal Carcinoid Cell Growth;Molecular Cancer Therapeutics;2010-01-26